Deferiprone for thalassaemia

Lancet. 2000 Oct 21;356(9239):1444-5. doi: 10.1016/S0140-6736(05)74089-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Administration, Oral
  • Deferiprone
  • Humans
  • Iron Chelating Agents / administration & dosage
  • Iron Chelating Agents / adverse effects*
  • Pyridones / administration & dosage
  • Pyridones / adverse effects*
  • Thalassemia / drug therapy*

Substances

  • Iron Chelating Agents
  • Pyridones
  • Deferiprone